1st Quarter - Report

AMERICAN SOCIETY OF NEPHROLOGY for AMERICAN SOCIETY OF NEPHROLOGY

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases

LobbyistCovered position, as disclosed
LAUREN AHEARN Quality and Regulatory Affairs Associate
KILLIAN GAUSE New —
ZACHARY D KRIBS New —
RACHEL NELL MEYER New Strategic Policy Advisor to the Executive Vice President
DAVID LEE WHITE Regulatory and Quality Officer

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA)

Bills named: H.R. 2761 (118th), H.R. 2544 (118th), H.R. 5074 (118th), H.R. 3674 (118th), H.R. 6171 (118th), H.R. 6860 (118th), H.R. 2389 (118th), S. 1384 (118th), S. 3211 (118th), H.R. 6205 (118th), S. 1668 (118th), H.R. 2923 (118th), H.R. 2474 (118th), S. 705 (118th), S. 1302 (118th)

Science/Technology SCI

FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Regulatory: Prioritize kidney health research, including inside the NIH

LobbyistCovered position, as disclosed
KILLIAN GAUSE New —
ZACHARY D KRIBS New —
RYAN MURRAY Senior Manager of Policy and Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.